- Product Details
Keywords
- hot sale Doxercalciferol
- Doxercalciferol suppulier
- High quality Doxercalciferol
Quick Details
- ProName: hot sale /High quality Doxercalciferol...
- CasNo: 54573-75-0
- Molecular Formula: C28H44O2
- Appearance: White crystalline powder
- Application: Synthetic vitamin D prohormone. A new ...
- DeliveryTime: ship immediately after confirmation
- PackAge: According to your demand
- Port: any port in China
- ProductionCapacity: Metric Ton/Day
- Purity: 99
- Transportation: as requested
- LimitNum: 1 Gram
Superiority
hot sale /High quality Doxercalciferol suppulier
Doxercalciferol is a synthetic vitamin D2 analog introduced in the US as Hectorol for the treatment of secondary hyperparathyroidism (SHPT) in patients with end-stage renal failure. It is actually 1-alpha-hydroxyvitamin D2 (one-alpha- D2) and can be synthesized by direct hydroxylation of vitamin D2 tosylate or in 5 steps from ergosterol. Doxercalciferol itself is inactive until metabolized by the liver into active 1,24-dihydroxyvitamin D2, showing a pharmacokinetic profile similar to calcitriol. During placebo-controlled clinical trials, patients with moderate to severe SHPT were treated with 1-alpha-D2 (10 μg doses) for 16 to 24 weeks; in 9 patients out of 10, blood levels of parathyroid hormone were considerably reduced, so maintaining a good control of the parathyroid hyperplasia. Moreover, only a moderate tendency to raise calcium and phosphate was observed. Doxercalciferol is orally-active and less toxic than other vitamin D analogs like alfacalcidol; it shows differentially controlled effects and has an improved safety profile compared to calcitriol
Doxercalciferol (other name: 1α-hydroxyvitamin D2), a synthetic vitamin D2 analog, was first synthesized from ergosterol [E0018].1) It is a prodrug requiring hepatic metabolism to the active metabolite 1α,25-dihydroxyvitamin D2 (1α, 25-(OH)2D2), a biologically active form of vitamin D2.2) The active vitamin D2 binds the vitamin D receptor (VDR) to result in the selective activation of vitamin D responsive pathway. It has been reported that doxercalciferol reduces parathyroid hormone (PTH) levels by inhibiting PTH synthesis and secretion.3) In clinical, doxercalciferol is used for the treatment of secondary hyperparathyroidism (2HPT) and metabolic bone disease.3,4) (The product is for research purpose only.)
Synthetic vitamin D prohormone. A new active Vitamin D analog which inhibits growth of human neuroblastoma. Antihyperparathyroid
Details
Name
Doxercalciferol
Synonyms
1ALPHA-OH-D2;1-alpha-hydroxyergocalciferol;1alpha-hydroxyergocalciferol;1-alpha-hydroxyvitamind2;1-hydroxyergocalciferol;7,10(19),22-tetraene-1,3-diol,(1-alpha,3-beta,5z,7e,22e)-10-secoergosta-5;VITAMIND2,1ALPHA-HYDROXY-;VitaminD2,1a-Hydroxy-
Molecular Formula
C28H44O2
Molecular Weight
412.65
CAS Number (Or Watson Number for Non-CAS Products)
54573-75-0
EINECS
Appearance
Specs/Standards
98%
Use
Doxercalciferol Intermediate.
Product Number | D5526 |
Purity / Analysis Method | >98.0%(HPLC) |
Molecular Formula / Molecular Weight | C28H44O2 = 412.66 |
Physical State (20 deg.C) | Solid |
Storage Temperature | -20°C |
Condition to Avoid | Heat Sensitive |
CAS RN | 54573-75-0 |
Reaxys Registry Number | 4716774 |
Merck Index (14) | 3436 |
MDL Number |
MFCD00871065 |